These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. A perspective on current and future uses of alternative models for carcinogenicity testing. Goodman JI Toxicol Pathol; 2001; 29 Suppl():173-6. PubMed ID: 11695554 [TBL] [Abstract][Full Text] [Related]
46. NTP announces bioassay results. Environ Health Perspect; 1995 Feb; 103(2):139. PubMed ID: 7737058 [No Abstract] [Full Text] [Related]
47. Drugs for the gynecologist to prescribe in the prevention of breast cancer: current status and future trends. Goldstein SR Am J Obstet Gynecol; 2000 May; 182(5):1121-6. PubMed ID: 10819845 [TBL] [Abstract][Full Text] [Related]
48. [Use of the data of quantitative analysis of organo-systemic distribution of tumors in the evaluation of real hazards of chemical carcinogens]. Kurliandskiĭ BA; Nevzorova NI Vopr Onkol; 1988; 34(5):577-80. PubMed ID: 3381500 [TBL] [Abstract][Full Text] [Related]
49. Comparative results of 327 chemical carcinogenicity studies. Haseman JK; Huff JE; Zeiger E; McConnell EE Environ Health Perspect; 1987 Oct; 74():229-35. PubMed ID: 3691430 [TBL] [Abstract][Full Text] [Related]
50. Re: Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors. Ménard S; Tagliabue E; Campiglio M; Balsari A J Natl Cancer Inst; 2000 Jun; 92(11):943-4. PubMed ID: 10841836 [No Abstract] [Full Text] [Related]
51. Chemoprevention for breast cancer: are we ready? Kiang DT J Natl Cancer Inst; 1991 Apr; 83(7):462-3. PubMed ID: 2005624 [No Abstract] [Full Text] [Related]
52. Tamoxifen prophylaxis in breast cancer. Love RR Oncology (Williston Park); 1992 Jul; 6(7):33-8; discussion 38-40, 43. PubMed ID: 1386239 [TBL] [Abstract][Full Text] [Related]
53. Concern over Prozac-induced tumor growth may dwindle following FDA study. Mathews J J Natl Cancer Inst; 1995 Sep; 87(17):1285-7. PubMed ID: 7658480 [No Abstract] [Full Text] [Related]
54. Tamoxifen for the reduction in the incidence of breast cancer in women at high risk for breast cancer. Honig SF Ann N Y Acad Sci; 2001 Dec; 949():345-8. PubMed ID: 11795374 [TBL] [Abstract][Full Text] [Related]
55. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens. Goodman G; Shlyakhter A; Wilson R Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542 [No Abstract] [Full Text] [Related]
56. [Carcinogenic activity of some Soviet drug preparations]. Tsapenko VF; Boĭm TM; Osin'kovskaia ND; Rubenchik BL Eksp Onkol; 1986; 8(3):75-6, 78. PubMed ID: 3720645 [TBL] [Abstract][Full Text] [Related]
57. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Cohen MH; Johnson JR; Li N; Chen G; Pazdur R Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats. Enginar N; Hatipoğlu I; Firtina M Pharmacol Biochem Behav; 2008 May; 89(3):450-5. PubMed ID: 18304624 [TBL] [Abstract][Full Text] [Related]
59. Hepatic tumours and other chronic liver changes in rats following a single oral administration of aflatoxin. Carnaghan RB Br J Cancer; 1967 Dec; 21(4):811-4. PubMed ID: 6074701 [No Abstract] [Full Text] [Related]